PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS.
a Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Feinberg School of Medicine , Northwestern University , Chicago , IL , USA.
Sameem
S
Abedin
a Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Feinberg School of Medicine , Northwestern University , Chicago , IL , USA.|b Department of Medicine , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA.
Leonidas C
LC
Platanias
D001374:Azacitidine / Q000031:analogs & derivatives; D060890:B7-H1 Antigen / Q000235:genetics; D000077209:Decitabine; D006801:Humans; D009190:Myelodysplastic Syndromes; D015854:Up-Regulation
D060890:B7-H1 Antigen; D000077209:Decitabine; D001374:Azacitidine